机构

• 上海药物研究所 [28]
• 自动化研究所 [7]
• 西北高原生物研究所 [4]
• 合肥物质科学研究院 [4]
• 广州地球化学研究所 [2]
• 深圳先进技术研究院 [1]
• 更多

采集方式

• OAI收割 [49]

内容类型

• 期刊论文 [46]
• 会议论文 [3]

发表日期

• 2024 [3]
• 2023 [2]
• 2022 [4]
• 2021 [5]
• 2020 [6]
• 2019 [4]
• 更多

学科主题

• 纳米科技与材料物理:... [2]

筛选

浏览/检索结果: 共49条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Design, Synthesis, and Biological Evaluation of Novel Diaminopyrimidine Macrocycles as Fourth Generation Reversible EGFR Inhibitors That Overcome Clinical Resistance to Osimertinib Mediated by C797S Mutation 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 67, 期号: 22, 页码: 20531-20558 作者:  Hu, Shiliang;  Tong, Linjiang;  Qin, Qiao;  Wen, Jiaxin;  Li, Yan   |  收藏  |  浏览/下载：8/0  |  提交时间：2024/12/11 Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation 期刊论文  OAI收割 SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 卷号: 9, 期号: 1, 页码: 17 作者:  Zhang, Tao;  Pan, Zilu;  Gao, Jing;  Wu, Qingqing;  Bai, Gang   |  收藏  |  浏览/下载：16/0  |  提交时间：2024/10/21 Comprehensive Attribute Prediction Learning for Person Search by Language 期刊论文  OAI收割 IEEE TRANSACTIONS ON IMAGE PROCESSING, 2024, 卷号: 33, 页码: 1990-2003 作者:  Niu, Kai;  Huang, Linjiang;  Long, Yuzhou;  Huang, Yan;  Wang, Liang   |  收藏  |  浏览/下载：19/0  |  提交时间：2024/07/03 Person search by language  cross-modal retrieval  smart video surveillance  attribute prediction   Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 12, 页码: 4748-4764 作者:     |  收藏  |  浏览/下载：24/0  |  提交时间：2024/01/26 Small molecule inhibitor  Tumor microenvironment  Immune-checkpoint  immune-deficient mouse models  including temozolomide (TMZ) insensitive tumors. Notably   Improving Inconspicuous Attributes Modeling for Person Search by Language 期刊论文  OAI收割 IEEE TRANSACTIONS ON IMAGE PROCESSING, 2023, 卷号: 32, 页码: 3429-3441 作者:  Niu, Kai;  Huang, Tao;  Huang, Linjiang;  Wang, Liang   |  收藏  |  浏览/下载：6/0  |  提交时间：2023/11/17 Person search by language  cross-modal retrieval  smart video surveillance   Novel Sphingosine Kinase 1 Inhibitor Suppresses Growth of Solid Tumor and Inhibits the Lung Metastasis of Triple-Negative Breast Cancer 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 65, 期号: 11, 页码: 7697-7716 作者:  Zhang, Shurui;  Chen, Xiaoxu;  Wu, Chenglin;  Xu, Hui;  Xie, Xiong   |  收藏  |  浏览/下载：36/0  |  提交时间：2022/08/16 SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors 期刊论文  OAI收割 CELL RESEARCH, 2022, 页码: 21 作者:  Wang, Xiaomin;  Chen, Ziqi;  Xu, Jun;  Tang, Shuai;  An, Nan   |  收藏  |  浏览/下载：61/0  |  提交时间：2022/06/15 Discovery of N-(3-bromo-1H-indol-5-yl)-quinazolin-4-amine as an effective molecular skeleton to develop reversible/irreversible pan-HER inhibitors 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 233, 页码: 13 作者:  Tang, Qidong;  Peng, Ting;  Hu, Jie;  Zhang, Tao;  Chen, Pengqin   |  收藏  |  浏览/下载：45/0  |  提交时间：2022/08/16 Reversible  irreversible pan-HER inhibitor  Quinazolin-4-amine derivatives  Anti-tumor  Structure-activity relationship   Multi-Modality Self-Distillation for Weakly Supervised Temporal Action Localization 期刊论文  OAI收割 IEEE TRANSACTIONS ON IMAGE PROCESSING, 2022, 卷号: 31, 页码: 1504-1519 作者:  Huang, Linjiang;  Wang, Liang;  Li, Hongsheng   |  收藏  |  浏览/下载：32/0  |  提交时间：2022/03/17 Location awareness  Reliability  Noise measurement  Annotations  Training  Head  Task analysis  Weakly supervised temporal action localization  multi-modality  pseudo label  self-distillation   LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo 期刊论文  OAI收割 CANCER SCIENCE, 2021, 页码: 12 作者:  Liu, Yingqiang;  Lai, Mengzhen;  Li, Shan;  Wang, Yanan;  Feng, Fang   |  收藏  |  浏览/下载：110/0  |  提交时间：2022/01/18 C797S  epidermal growth factor receptor  fourth-generation EGFR TKI  non-small cell lung cancer  osimertinib resistance